AbbVie
ABBV
#26
Rank
A$569.76 B
Marketcap
$322.09
Share price
0.71%
Change (1 day)
16.48%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Net assets

Net assets on the balance sheet as of December 2024 : A$5.34 Billion

According to AbbVie's latest financial reports the company has A$5.34 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

AbbVie - Net assets on balance sheet (from 2011 to 2024)

Net assets by year

Year Net assets Change
2024-12-31$A$5.40 B-64.56%
2023-12-31$A$15.26 B-39.93%
2022-12-31$A$25.40 B19.31%
2021-12-31$A$21.29 B25%
2020-12-31$A$17.03 B-245.93%
2019-12-31$-A$11.68 Billion-2.65%
2018-12-31$-A$11.99 Billion-283.64%
2017-12-31$A$6.52 B1.51%
2016-12-31$A$6.43 B18.77%
2015-12-31$A$5.41 B154.41%
2014-12-31$A$2.12 B-57.73%
2013-12-31$A$5.03 B55.62%
2012-12-31$A$3.23 B-72.19%
2011-12-31$A$11.63 B-24.72%
2010-12-31$A$15.45 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
A$140.60 B 2,530.71%๐Ÿ‡บ๐Ÿ‡ธ USA
A$26.03 B 387.16%๐Ÿ‡บ๐Ÿ‡ธ USA
A$22.67 B 324.24%๐Ÿ‡บ๐Ÿ‡ธ USA
A$9.33 B 74.70%๐Ÿ‡บ๐Ÿ‡ธ USA
A$30.57 B 472.12%๐Ÿ‡บ๐Ÿ‡ธ USA
A$26.55 B 396.91%๐Ÿ‡บ๐Ÿ‡ธ USA
A$26.09 B 388.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$64.93 B 1,114.95%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$4.11 B-23.02%๐Ÿ‡บ๐Ÿ‡ธ USA